• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

6.670 +0.500 (+8.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,927
Open 6.120
Bid (Size) 6.060 (500)
Ask (Size) 6.880 (400)
Prev. Close 6.170
Today's Range 6.079 - 6.700
52wk Range 3.755 - 9.400
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harvard Bioscience Announces Second Quarter 2026 Financial Results
August 11, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
July 28, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire

Performance

YTD
+2.3%
+2.3%
1 Month
+12.5%
+12.5%
3 Month
+20.8%
+20.8%
6 Month
+19.1%
+19.1%
1 Year
+33.4%
+33.4%

More News

Read More
News headline image
Sidoti Events, LLC's May Micro-Cap Virtual Conference
May 20, 2026
Via ACCESS Newswire
News headline image
HBIO Q1 2026 Earnings Transcript ↗
May 12, 2026
Via The Motley Fool
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
May 12, 2026
Via Chartmill
Harvard Bioscience Inc. (NASDAQ:HBIO) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
March 12, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
Harvard Bioscience Announces First Quarter 2026 Financial Results
May 12, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in Upcoming Investor Conferences
May 07, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
April 28, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience (HBIO) Earnings Transcript ↗
March 12, 2026
Via The Motley Fool
Topics World Trade
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
March 12, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
March 06, 2026
Via Chartmill
News headline image
Harvard Bioscience Announces Reverse Stock Split
March 06, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
March 03, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
February 26, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
February 10, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
January 29, 2026
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
December 17, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q3 2025 Results Amid Restructuring Efforts ↗
November 06, 2025
Via Chartmill
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
November 06, 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
October 31, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 30, 2025
Via Benzinga
News headline image
These stocks are moving in today's session ↗
October 30, 2025
Via Chartmill
News headline image
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
October 30, 2025
Via AB Newswire
Topics Artificial Intelligence Fraud

Frequently Asked Questions

Is Harvard Bioscience, Inc. - Common Stock publicly traded?
Yes, Harvard Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Harvard Bioscience, Inc. - Common Stock trade on?
Harvard Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harvard Bioscience, Inc. - Common Stock?
The ticker symbol for Harvard Bioscience, Inc. - Common Stock is HBIO on the Nasdaq Stock Market
What is the current price of Harvard Bioscience, Inc. - Common Stock?
The current price of Harvard Bioscience, Inc. - Common Stock is 6.670
When was Harvard Bioscience, Inc. - Common Stock last traded?
The last trade of Harvard Bioscience, Inc. - Common Stock was at 08/13/26 04:00 PM ET
What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
The market capitalization of Harvard Bioscience, Inc. - Common Stock is 284.73M
How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
Harvard Bioscience, Inc. - Common Stock has 285M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap